Atlas Trials

CyanVac LLC

4 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch CyanVac LLC

RecordFirmDate
A Phase 1 Trial of Intranasal Mumps Virus Vaccines in Healthy Adults (NCT06967181)CyanVac LLC2025-05-14
A Phase 2b, Randomized, Double-blind, Active-controlled Study of Single Dose CVXGA Intranasal COVID-19 Vaccine in Adults (NCT06742281)CyanVac LLC2024-12-05
A Phase 2 Trial of the Immunogenicity and Safety of CVXGA Intranasal COVID Vaccine in Healthy Adults (NCT05736835)CyanVac LLC2023-09-21
Phase 1 Study of Intranasal PIV5 COVID-19 Vaccine Expressing SARS-CoV-2 Spike Protein in Healthy Adults and Adolescents (NCT04954287)CyanVac LLC2021-08-06

Track CyanVac LLC automatically

Every clearance here is in the API, with alerts when new ones post.